AbbVie Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -24.42. In total, the insiders bought 564 555 and sold 918 577 ABBV shares in the last 100 trades.

Insider Power

(Last 100 transactions)
-24.42
Buy 564 555 Shares
Sell 918 577 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 30, 2024 Stock Equivalent Units Buy Quaggin Susan E 87
Jun 30, 2024 Stock Equivalent Units Buy Rapp Edward J 225
Jun 30, 2024 Stock Equivalent Units Buy Alpern Robert J 43
Jun 28, 2024 Common Stock, $0.01 par value Sell Gonzalez Richard A 6 000
May 03, 2024 Common Stock, $0.01 par value Buy Davis Jennifer L. 1 322
May 03, 2024 Common Stock, $0.01 par value Buy Quaggin Susan E 1 322
May 03, 2024 Common Stock, $0.01 par value Buy Rapp Edward J 1 322
May 03, 2024 Common Stock, $0.01 par value Buy Alpern Robert J 1 322
May 03, 2024 Common Stock, $0.01 par value Buy Freyman Thomas C 1 322
May 03, 2024 Common Stock, $0.01 par value Buy Austin Roxanne S 1 322
May 03, 2024 Common Stock, $0.01 par value Buy Hart Brett J 1 322
May 03, 2024 Common Stock, $0.01 par value Buy Meyer Melody B 1 322
May 03, 2024 Common Stock, $0.01 par value Buy Roberts Rebecca B 1 322
May 03, 2024 Common Stock, $0.01 par value Buy Burnside William H.l. 1 322
May 03, 2024 Common Stock, $0.01 par value Buy Tilton Glenn F 1 322
May 03, 2024 Common Stock, $0.01 par value Buy Waddell Frederick H 1 322
Mar 31, 2024 Stock Equivalent Units Buy Quaggin Susan E 82
Mar 31, 2024 Stock Equivalent Units Buy Alpern Robert J 41
Mar 31, 2024 Stock Equivalent Units Buy Rapp Edward J 212
Mar 20, 2024 Common Stock, $0.01 par value Sell Donoghoe Nicholas 21 082
Mar 18, 2024 Common Stock, $0.01 par value Buy Stewart Jeffrey Ryan 26 110
Mar 18, 2024 Common Stock, $0.01 par value Sell Stewart Jeffrey Ryan 26 110
Mar 18, 2024 Common Stock, $0.01 par value Sell Stewart Jeffrey Ryan 5 099
Mar 18, 2024 Common Stock, $0.01 par value Sell Stewart Jeffrey Ryan 27 740
Mar 18, 2024 Option (Right to Buy) Sell Stewart Jeffrey Ryan 26 110
Click to get the best stock tips daily for free!

About AbbVie Inc

AbbVie AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ... ABBV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT